882 results on '"Murthy, Sudish C"'
Search Results
2. Adjuvant Therapy after Esophagectomy for Esophageal Cancer: Who Needs It?: Multi-institution Worldwide Observational Study
3. Five-year experience with titanium mesh for rigid chest wall reconstruction
4. Quantifying the subjective: length-to-height ratio characterizes achalasia esophageal tortuosity
5. Preoperative predictors of spread through air spaces in lung cancer
6. Thoracoabdominal Esophagectomy: Then and Now
7. Clinical T2 N0 M0 Esophageal Cancer: Identifying Predictive Factors of Upstaging
8. Paraconduit hernia following esophagectomy: Is it safe to watch and wait?
9. Development and validation of a universal esophageal patient-reported outcome measure: The Cleveland Clinic Esophageal Questionnaire (CEQ)
10. The Value of Fundoplication in the Treatment of Type I Achalasia
11. Intraoperative Molecular Imaging With Pafolacianine: Histologic Characteristics of Identified Nodules
12. Routine use of jejunostomy tubes after esophagectomy: The good, the bad, and the ugly!
13. Pafolacianine for intraoperative molecular imaging of cancer in the lung: The ELUCIDATE trial
14. Effect of donor smoking and substance use on post–lung transplant outcomes
15. Accuracy of Endoscopic Biopsies for Determining Tumor Grade in Pre-resection Evaluation of Esophageal Adenocarcinoma
16. A comparative study of robotic and laparoscopic approaches to Heller myotomy
17. Adjuvant Therapy After Neoadjuvant Therapy for Esophageal Cancer: Who Needs It?
18. Endoscopic pyloromyotomy is feasible and effective in improving post–lung transplant gastroparesis
19. Select octogenarians with stage IIIa non–small cell lung cancer can benefit from trimodality therapy
20. How Much Delay Matters? How Time to Treatment Impacts Overall Survival in Early Stage Lung Cancer
21. Pleural space management after lung transplant: Early and late outcomes of pleural decortication
22. Non–small cell lung cancer in never- and ever-smokers: Is it the same disease?
23. Intercostal Blocks with Liposomal Bupivacaine in Thoracic Surgery: A Retrospective Cohort Study
24. Looking beyond the eyeball test: A novel vitality index to predict recovery after esophagectomy
25. Natural History of Pleural Complications After Lung Transplantation
26. Urgently listed lung transplant patients have outcomes similar to those of electively listed patients
27. Signet Ring Cell Histology Confers Worse Overall Survival in Treated Esophageal Adenocarcinoma
28. Optimal planning and management strategies for minimally invasive lung segmentectomies: an international Delphi consensus report.
29. Siewert III Adenocarcinoma: Still Searching for the Right Treatment Combination
30. Multidisciplinary Evaluation and Management of Early Stage Esophageal Cancer
31. Current Indications for Pulmonary Metastasectomy
32. Robotic Approach Offers Similar Nodal Upstaging to Open Lobectomy for Clinical Stage I Non-small Cell Lung Cancer
33. Clinical T2N0M0 Esophageal Cancer – Identifying Predictive Factors of Upstaging
34. Consequences of Delayed Chest Closure During Lung Transplantation
35. Per oral endoscopic myotomy: Another tool in the toolbox
36. Reintervention After Heller Myotomy for Achalasia: Is It Inevitable?
37. Patterns of Recurrence and Overall Survival in Incidental Lung Cancer in Explanted Lungs
38. Evolution of Recipient Characteristics Over 3 Decades and Impact on Survival After Lung Transplantation
39. Preoperative Predictors of Spread Through Air Spaces (STAS) in Lung Cancer
40. Value of Lymphadenectomy in Patients Receiving Neoadjuvant Therapy for Esophageal Adenocarcinoma
41. Low pretransplant IgA level is associated with early post–lung transplant seromucous infection
42. Value of routine timed barium esophagram follow-up in achalasia after myotomy
43. Largely Unchanged Annual Incidence and Overall Survival of Pleural Mesothelioma in the USA
44. Paraconduit hernia following esophagectomy: Is it safe to watch and wait?
45. Development and Validation of a Universal Esophageal Patient-Reported Outcome Measure: the Cleveland Clinic Esophageal Questionnaire (CEQ)
46. The Value of Fundoplication in the Treatment of Type I Achalasia.
47. The Value of Fundoplication in the Treatment of Type I Achalasia
48. How important is coronary artery disease when considering lung transplant candidates?
49. Importance of residual primary cancer after induction therapy for esophageal adenocarcinoma
50. Routine venous thromboembolism screening after pneumonectomy: The more you look, the more you see
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.